Connectivity as a Biomarker for Future Fragile X Clinical Trials

Connectivity as a Biomarker for Future Fragile X Clinical Trials

With a 2017 grant from FRAXA Research Foundation of $90,000, Dr. Andreas Frick’s team at Neurocentre Magendie, in France, will test non-invasive imaging using magnetic resonance imaging (MRI) as a potential biomarker for future Fragile X syndrome clinical trials.

Read more

Channelopathies: Altered Ion Channels in Fragile X Syndrome

Channelopathies: Altered Ion Channels in Fragile X Syndrome

With a $95,000 grant from FRAXA Research Foundation from 2010-2011, Dr. Daniel Johnston and Dr. Darrin Brager at the University of Texas at Austin investigated alterations in ion channels in Fragile X syndrome. They explored potential therapeutic effects of drugs which open and close these channels. Results published.

Read more